Log in to save to my catalogue

An Update in the Use of Antibodies to Treat Glioblastoma Multiforme

An Update in the Use of Antibodies to Treat Glioblastoma Multiforme

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3835613

An Update in the Use of Antibodies to Treat Glioblastoma Multiforme

About this item

Full title

An Update in the Use of Antibodies to Treat Glioblastoma Multiforme

Publisher

Cairo, Egypt: Hindawi Limiteds

Journal title

Autoimmune Diseases, 2013-01, Vol.2013 (2013), p.144-157

Language

English

Formats

Publication information

Publisher

Cairo, Egypt: Hindawi Limiteds

More information

Scope and Contents

Contents

Glioblastoma is a deadly brain disease and modest improvement in survival has been made. At initial diagnosis, treatment consists of maximum safe surgical resection, followed by temozolomide and chemoirradiation or adjuvant temozolomide alone. However, these treatments do not improve the prognosis and survival of patients. New treatment strategies...

Alternative Titles

Full title

An Update in the Use of Antibodies to Treat Glioblastoma Multiforme

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3835613

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3835613

Other Identifiers

ISSN

2090-0430,2090-0422

E-ISSN

2090-0430

DOI

10.1155/2013/716813

How to access this item